These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34689017)

  • 1. David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma.
    Filippi L; Frantellizzi V; De Vincentis G
    Cancer Treat Res Commun; 2021; 29():100478. PubMed ID: 34689017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted radionuclide therapy: frontiers in theranostics.
    Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
    Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha emitting nuclides in nuclear medicine theranostics.
    Miederer M
    Nuklearmedizin; 2022 Jun; 61(3):273-279. PubMed ID: 34624903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Advances in Breast Cancer in Nuclear Medicine.
    Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice.
    Sheikhbahaei S; Sadaghiani MS; Rowe SP; Solnes LB
    AJR Am J Roentgenol; 2021 Aug; 217(2):495-506. PubMed ID: 34076455
    [No Abstract]   [Full Text] [Related]  

  • 6. An introduction to the clinical practice of theranostics in oncology.
    Turner JH
    Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastasis: An insight into novel molecular targets for theranostic approaches.
    Santos L; Moreira JN; Abrunhosa A; Gomes C
    Crit Rev Oncol Hematol; 2024 Jun; 198():104377. PubMed ID: 38710296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic approaches in nuclear medicine: current status and future prospects.
    Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
    Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
    [No Abstract]   [Full Text] [Related]  

  • 9. MC1R and melanin-based molecular probes for theranostic of melanoma and beyond.
    Shi H; Cheng Z
    Acta Pharmacol Sin; 2022 Dec; 43(12):3034-3044. PubMed ID: 36008707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide-based theranostics - a promising strategy for lung cancer.
    Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts.
    Zhuravlev F
    Curr Radiopharm; 2021; 14(4):374-393. PubMed ID: 33357190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
    Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
    Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
    Polyak A; Ross TL
    Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
    Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
    J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.
    Zhang C; Lin KS; Bénard F
    Mol Imaging; 2017; 16():1536012117737919. PubMed ID: 29182034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
    Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
    Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
    Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
    Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics of Metastatic Prostate Cancer Applying
    Mirzaei S; Mohammed F; Zandieh S
    Curr Radiopharm; 2021; 14(4):354-358. PubMed ID: 32900357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.
    Agrawal A; Rangarajan V; Shah S; Puranik A; Purandare N
    Br J Radiol; 2018 Nov; 91(1091):20180103. PubMed ID: 30048149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.